SomnoMedSOMNF 49 Days Inventory is 57.81 as of Dec. 2025, which is 12% below its 10-year median of 65.79. GuruFocus rates SOMNF with a GF Score™ of 49/100 and a GF Value™ of $0.33 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, SomnoMed ranks better than 93.38% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). SomnoMed's Average Total Inventories for the
six
months ended in Dec. 2025 was $4.94 Mil. SomnoMed's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $15.60 Mil.
Hence, SomnoMed's Days Inventory for the
six
months ended in Dec. 2025 was 57.81.
The historical rank and industry rank for SomnoMed's Days Inventory or its related term are showing as below:
SOMNF'
s Days Inventory Range Over the Past 10 Years
Min: 55.57 Med: 65.79 Max: 103.8
Current: 55.57
During the past 13 years, SomnoMed's highest Days Inventory was 103.80. The lowest was 55.57. And the median was 65.79.
SOMNF's Days Inventory is ranked better than 93.38% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SOMNF: 55.57
SomnoMed's Days Inventory
declined
from Dec. 2024 (88.13) to Dec. 2025 (57.81).
Inventory Turnover measures how fast the company turns over its inventory within a year.
SomnoMed's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.16.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
SomnoMed's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.12.
SomnoMed (OTCPK:SOMNF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
SomnoMed's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
SomnoMed's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
SomnoMed Days Inventory Related Terms
SomnoMed Days Inventory Historical Data
* Premium members only.
The historical data trend for SomnoMed's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SomnoMed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SomnoMed Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's Days Inventory distribution charts can be found below:
* The bar in red indicates where SomnoMed's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SomnoMed (SOMNF) has a Days Inventory of 57.81 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on SomnoMed and its competitors. This is 12% below median its historical median of 65.79. Over the past decade, SomnoMed's Days Inventory has ranged from 55.57 to 103.80. According to the industry distribution chart, SomnoMed ranks #52 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 6.6%.
Is SomnoMed's Days Inventory too high?
SomnoMed's current Days Inventory of 57.81 is 12% below median its 10-year median of 65.79. Over the past 10 years, this metric has ranged from a low of 55.57 to a high of 103.80. The Medical Devices & Instruments industry median Days Inventory is 179.60. SomnoMed's value of 57.81 is 67.8% below this industry median. Based on the distribution chart, SomnoMed ranks #52 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SomnoMed has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SomnoMed ranks #52 out of 786 companies for Days Inventory. This places SomnoMed in the top 7% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. SomnoMed's value of 57.81 is 67.8% below this benchmark. Historically, SomnoMed's own Days Inventory has ranged from 55.57 to 103.80 over the past decade. While the company's 10-year median is 65.79 vs. the industry median of 179.60, SomnoMed has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SomnoMed's current Days Inventory of 57.81 is 67.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on SomnoMed and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SomnoMed's current Days Inventory is 57.81, which is 12% below median its own 10-year median of 65.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
Based on GuruFocus' analysis, SomnoMed (SOMNF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.33, compared to a current price of $0.45 — trading 35.7% above its estimated fair value. The current Days Inventory is 57.81, which is 12% below median its 10-year median of 65.79 and 67.8% below the Medical Devices & Instruments industry median of 179.60. SomnoMed's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For SomnoMed (SOMNF), the current Days Inventory is 57.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SomnoMed (SOMNF) Overvalued in 2026?
Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued.
The current stock price of $0.45 is trading 35.7% above its estimated GF Value™ of $0.33.
GuruFocus considers SomnoMed to be Significantly Overvalued.
Key valuation signals for SOMNF:
Days Inventory: 57.81 (12% below median its 10-year median of 65.79)
GF Value™: $0.33 vs. price of $0.45 (35.7% above fair value)
Industry Position: 67.8% below the Medical Devices & Instruments median (#52 of 786)
No single metric tells the full story. See the SOMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
49GF Score
Get the complete analysis for SOMNF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOMNF has been successfully added to your 
